Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Psychiatry
•
Primary Care
•
Geriatric Medicine
•
geriatric psyc
How would you recommend cross-titrating from paroxetine to another SSRI with less anticholinergic burden in an older adult?
Any pearls or tips re: how to design a taper strategy and when to start the alternative agent?
Related Questions
How do you decide when to initiate medical workup (e.g., thyroid, B12, infection) in a geriatric patient experiencing new onset or worsening low mood?
What is your approach to deprescribing gabapentinoids so as to prevent withdrawal effects?
What is your approach to initiation of mirtazapine for appetite stimulation and depression in older adults, both in terms of starting dose and titration?
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
What is your approach to a newly diagnosed LBBB in individuals >70 years old who are free of any signs or symptoms of heart disease and without other significant ASCVD risk factors besides age?
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?
Is a target TSH closer to the mid normal range justified in older individuals (age 70 or above) without any known cardiac ischemia or dysrhythmia or osteoporosis?
How do you recommend counseling patients on the prognosis of advanced cancer as a generalist who is not highly specialized in cancer literature or cancer-directed therapies?
How do you choose among SSRIs and dosing strategies for the management of behavioral and psychological symptoms of dementia?